The long-awaited hearing to discuss cannabis rescheduling will begin on January 21, 2025, marking a significant moment in the ongoing debate over cannabis regulation. As Business of Cannabis reported, the six-week hearing will continue until March 6, 2025, but its outcome remains uncertain due to political and procedural challenges. With key positions in the new administration … [Read more...] about DEA’s Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
DEA
DEA Counsel Dodges Question on Support for Cannabis Rescheduling
Pro-cannabis rescheduling attorney Matthew Zorn, partner at Yetter Coleman LLP, has an exchange with John J. Mulrooney, the Drug Enforcement Administration's chief administrative law judge, during preliminary proceedings Dec. 2 in Arlington, Va. Drug Enforcement Administration The Drug Enforcement Administration’s lead counsel appeared to sidestep the very first question an … [Read more...] about DEA Counsel Dodges Question on Support for Cannabis Rescheduling
Rescheduling Hearings Begin: Not About If Marijuana “Good or Bad,” Says Judge
The first Drug Enforcement Administration (DEA) hearing on the Biden administration’s cannabis rescheduling proposal took place on December 2, with proponents and opponents appearing for a largely procedural meeting to prepare for more substantive hearings in 2025. The judge overseeing the proceedings made clear that the hearings are not meant to determine “whether marijuana is … [Read more...] about Rescheduling Hearings Begin: Not About If Marijuana “Good or Bad,” Says Judge
DEA to Consider Loosening Federal Marijuana Restrictions
THE CENTER SQUARE—The Drug Enforcement Administration plans to hold a formal hearing next week on its plan to reschedule marijuana at the federal level.The proposal is to move marijuana from a Schedule I drug, along with heroin and LSD, to Schedule III, where it would join ketamine and anabolic steroids.In May, the Department of Justice announced that it had submitted a rule … [Read more...] about DEA to Consider Loosening Federal Marijuana Restrictions
Smart Approaches to Marijuana Responds to Claims It Colluded With DEA
Cannabis prohibitionist group Smart Approaches to Marijuana (SAM) responded to claims on Nov. 25 that it improperly communicated with the Drug Enforcement Administration (DEA) leading up to next week’s cannabis rescheduling hearing.The hearing, to determine the proper schedule for cannabis under the Controlled Substances Act (CSA), will commence with preliminary proceedings on … [Read more...] about Smart Approaches to Marijuana Responds to Claims It Colluded With DEA
DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing
The Drug Enforcement Administration (DEA) responded to a slew of allegations on Nov. 25, including that it engaged in illegal communications and conspired with a prohibitionist group ahead of a cannabis rescheduling hearing that is set to begin next week. A pair of cannabis rescheduling advocates whom the DEA selected to be among the 25 designated participants for the … [Read more...] about DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing
DEA Reschedules Rescheduling, and I’m Feeling a Little Like Charlie Brown Trying to Kick the Football
No, it’s not (just) a cruel play on words. Last week, the Drug Enforcement Administration announced that a much-anticipated public hearing on the proposal to reschedule marijuana was being pushed from early December until the first quarter of 2025. I’m not sure I specifically predicted this, but it’s just about the most predictable thing ever. And it has a number of people … [Read more...] about DEA Reschedules Rescheduling, and I’m Feeling a Little Like Charlie Brown Trying to Kick the Football
DEA Calls For Increased Production Of Some Psychedelics For Research, As Marijuana Quotas Level Out Ahead Of Scheduling Decision
The Drug Enforcement Administration (DEA) has released new quotas for the production of Schedule I and Schedule II controlled substances for research purposes—calling for an increase in the manufacturing of the psychedelics ibogaine, psilocybin and psilocyn, while continuing to maintain stable quotas for other substances such as marijuana, THC and MDMA. As DEA prepares to hold … [Read more...] about DEA Calls For Increased Production Of Some Psychedelics For Research, As Marijuana Quotas Level Out Ahead Of Scheduling Decision
Slow Your Roll: IRS Reminds Taxpayers That Cannabis Has Not Yet Been Reclassified
Weeks after the U.S. Drug Enforcement Administration (DEA) announced that it would move to reclassify cannabis as a less dangerous drug, the IRS is reminding taxpayers that marijuana remains a Schedule I controlled substance and is subject to the limitations of the tax code. In other words, the federal tax laws related to cannabis sales have not changed. Legalization Of … [Read more...] about Slow Your Roll: IRS Reminds Taxpayers That Cannabis Has Not Yet Been Reclassified
DEA Report Reflects Average Potency of THC in Illegal Cannabis at 16%
The Drug Enforcement Administration (DEA) recently released a report on May 9 with details about its 2024 National Drug Threat Assessment (NDTA), which is dedicated to compiling data in relation to illegal drugs and trafficking trends within the U.S. DEA Administrator Anne Milgram introduced the report to warn of the many threats to public safety as well as national security. … [Read more...] about DEA Report Reflects Average Potency of THC in Illegal Cannabis at 16%
